The road to a first commercial launch is exciting, and yes, stressful at times. But when helping to bring a lifesaving or life-changing new therapy to patients, it’s worth the trip.
Lessons Learned from Rare Disease First Commercial Launches
Among the keys to a successful global launch: Achieving world peace
Launching a global rare disease brand is exciting, as well as uniquely challenging at times.
Attracting the Workforce of the Future
We can draw more of the next generation into our workforce when we help them connect what we do to the bigger picture, which can be easy to lose sight of on a daily basis.
Dudnyk Wins Two Pharma Choice Awards from PM360
Simon’s Heart awarded Gold and Eyevance earns Silver.
The Rise of the Empowered Patient
Many of the rare disease advocacy groups that exist today were started or inspired by parents looking to draw attention and resources to their children’s conditions, and their passion and hard work
The Implementation of Universal Genetic Screening
Genetic screening offers a powerful insight into our genome, which, by identifying thousands of genetic diseases, will help lead to improved patient care and treatment, and also to the next wave of
Can Healthcare Be Equitable?
Even with these unparalleled strengths, millions of people struggle each day to gain access to the best treatments and to pay for their medication, and feel unprotected by our healthcare system.
The Need for Education
As industry leaders, we should be breaking down these barriers and driving patients to the answers they need, and ultimately, to life-changing treatments.
How to attract the workforce of the future
Laurie Bartolomeo shares her thoughts on how to inspire the next generation in the December issue of PharmaVOICE.
Ten Things Every Family Living with a Rare Disease Needs to Know
In the December issue of PM360, Laurie Bartolomeo lists ten ways that companies, marketers, and HCPs can empower patients and families living with rare disease.
MM&M Partner Forum: Not really that rare
Chris Tobias reveals how Dudnyk supports our clients in the rare disease space. Earning trust must come first.
Dudnyk Wins PM360 Trailblazer Award for Philanthropic Initiative
Simon’s Heart awarded Best Consumer Website/Online Initiative
Dudnyk's Tim Anderson on the Enduring Value of Chemotherapy in Cancer Care
In the new age of innovative oncology therapies, chemotherapy still plays a critical role in cancer care.
Agency CEO Roundtable
In the September issue of PharmaVOICE, Chris Tobias discusses why the strength of the empowered patient is the greatest fundamental shift in our industry.
Dudnyk Named Finalist for Multiple Trailblazer Awards
Dudnyk is proud to have been named a finalist five times for the upcoming PM360 Magazine #TrailblazerAwards.
Drew Desjardins Named to PharmaVOICE 100
Drew Desjardins has been recognized as one of the inspirational leaders of our industry. Read what our “Chief Problem Solver” has to say about collaborative thinking and groundbreaking strategy.
Dudnyk Shortlisted for Four MM&M Awards
Dudnyk has been nominated in four categories for this year’s MM&M Awards, including for our philanthropic and rare disease work.
Dudnyk Listed as Top 100 Agency in July MM&M
Dudnyk has been listed again in the annual agency issue. Read to learn more about our revenue increases, recent growth, and ongoing projects.
From Isolation to Anticipation
Laurie Bartolomeo shares how technology continues to improve the lives of rare disease families in the July issue of MedAd News.
WOW! Laurie Bartolomeo Featured in PharmaVOICE Woman of the Week Podcast
Laurie Bartolomeo talks to PharmaVOICE about her career journey and how her son’s rare disease is a source of inspiration.
Planning your next project?
Work with usDownload our fact sheet
Click hereConnect with us
© Dudnyk. All rights reserved.
Trademarks are the property of their respective owners.